Stock Research for LXRP

LXRP

Featured Broker: Ally Invest

Get the due diligence for another stock.

 

LXRP Stock Chart & Research Data

The LXRP chart settings shown below allow you to select time intervals of 1 min, 30 mins, an hour or by day - week - month. There is also the ability to change the LXRP chart style to candles, hollow candles, bars, lines or add various indicators. You can even add a symbol and compare history.


 


LXRP Due diligence Resources & Stock Charts

The LXRP stock resources shown below were gathered to cut back on time by allowing you to visit multiple sites at once. For your convenience each link clicked will open in a window. In addition to the individual links there is a button at the bottom that will allow you to open all the links at the same time. Note opening all links at once may not work with all browsers. Some browsers block multiple windows, to resolve this please allow that site to use pop-ups.

The Four Most Popular Resources

CNN View LXRP Detailed Price Forecast - CNN Money CNN View LXRP Detailed Summary - Google Finance
Yahoo View LXRP Detailed Summary - Yahoo! Finance Zacks View LXRP Stock Research & Analysis - Zacks.com

Stock Analysis

TradeIdeas View LXRP Trends & Analysis - Trade-Ideas Barrons View LXRP Major Holders - Barrons
NASDAQ View LXRP Call Transcripts - NASDAQ Seeking View LXRP Breaking News & Analysis - Seeking Alpha
Spotlight View LXRP Annual Report - CompanySpotlight.com OTC Report View LXRP OTC Short Report - OTCShortReport.com
TradeKing View LXRP Fundamentals - TradeKing Charts View LXRP SEC Filings - Bar Chart
WSJ View Historical Prices for LXRP - The WSJ Morningstar View Performance/Total Return for LXRP - Morningstar
MarketWatch View the Analyst Estimates for LXRP - MarketWatch CNBC View the Earnings History for LXRP - CNBC
StockMarketWatch View the LXRP Earnings - StockMarketWatch MacroAxis View LXRP Buy or Sell Recommendations - MacroAxis
Bullish View the LXRP Bullish Patterns - American Bulls Short Pains View LXRP Short Pain Metrics - ShortPainBot.com

Social Media Mentions

StockTwits View LXRP Stock Mentions - StockTwits PennyStocks View LXRP Stock Mentions - PennyStockTweets
Twitter View LXRP Stock Mentions - Twitter Invest Hub View LXRP Investment Forum News - Investor Hub
Yahoo View LXRP Stock Mentions - Yahoo! Message Board Seeking Alpha View LXRP Stock Mentions - Seeking Alpha


Financial & Transaction Holdings

SECform4 View Insider Transactions for LXRP - SECform4.com Insider Cow View Insider Transactions for LXRP - Insider Cow
CNBC View LXRP Major Holdings Summary - CNBC OTC Markets View Insider Disclosure for LXRP - OTC Markets
Yahoo View Insider Transactions for LXRP - Yahoo! Finance NASDAQ View Institutional Holdings for LXRP - NASDAQ


Stock Charts

FinViz View LXRP Stock Insight & Charts - FinViz.com StockCharts View LXRP Investment Charts - StockCharts.com
BarChart View LXRP Stock Overview & Charts - BarChart Trading View View LXRP User Generated Charts - Trading View




Latest Financial News for LXRP


Lexaria Bioscience Provides Update on R&D Program Progress under License Agreement with Altria
Posted on Tuesday October 08, 2019

KELOWNA, BC / ACCESSWIRE / October 8, 2019 / Lexaria Bioscience Corp. (LXRP) (LXX.CN) (the "Company" or "Lexaria"), a global innovator in drug delivery platforms, is pleased to provide this update on the ongoing relationship and pursuit of innovation in oral, reduced risk nicotine consumer products using Lexaria's patented DehydraTECHTM technology, underway between Altria Ventures Inc., an indirect wholly owned subsidiary of Altria Group, Inc (NYSE:MO) ("Altria") and Lexaria's majority owned subsidiary Lexaria Nicotine LLC ("Lexaria Nicotine"). Most of the investigation and work within this first phase of the project is either complete or significantly underway, with one remaining aspect ready to commence imminently.


Peer Reviewed Clinical Journal Publishes Lexaria Bioscience's Human CBD Study Results
Posted on Tuesday September 17, 2019

KELOWNA, BRITISH COLUMBIA / ACCESSWIRE / September 17, 2019 / Lexaria Bioscience Corp. (LXRP)(LXX.CN) (the “Company” or “Lexaria”), a global innovator in drug delivery platforms, is pleased to announce that final study results of the 2018 human clinical study evaluating CBD delivery and effectiveness using its patented DehydraTECHTM powered TurboCBD™ capsules have been published in the peer reviewed medical journal, “Advances in Therapy”. Advances in Therapy focuses on clinical medicine and pharmaceutical research and has been published continually since 1984.


Lexaria Bioscience Corp. (CSE: LXX) (OTCQX: LXRP) Featured in NetworkNewsAudio Publication Discussing Innovative Drug-Delivery Discovery
Posted on Friday September 06, 2019

While effectiveness of drugs is what most often captures the spotlight, that effectiveness is closely associated with the drug-delivery technology used, and innovation in this space may have a huge impact on how successful a drug can be. Lexaria Bioscience Corp.’s DehydraTECH(TM) may be the most novel form of drug delivery discovered in decades. Fatty acids used in the technology mask the smell and taste of the drug and potentially greatly reduce stomach upset.


Lexaria Bioscience Announces DehydraTECH Patent for Pharmaceutical Applications of Cannabinoids to Treat Certain Disease Conditions
Posted on Tuesday August 27, 2019

KELOWNA, BC / ACCESSWIRE / August 27, 2019 / Lexaria Bioscience Corp. (LXRP) (LXX.CN) (the “Company” or “Lexaria”), a global innovator in drug delivery platforms, is pleased to announce that it has received a new patent granted in Australia: #2016367037 / Grant Date August 15, 2019 - “Stable ready-to-drink beverage compositions comprising lipophilic active agents”. Lexaria’s patent portfolio has increased to 16 awarded patents protecting its DehydraTECH™ drug delivery platform, with 8 granted in the USA and 8 granted in Australia. This new Australian patent, together with Australian Patent #2016367036 “Methods for formulating orally ingestible compositions comprising lipophilic active agents” announced on August 15, 2019, are the first patents granted in Lexaria’s second and third patent families which differ from the Company’s original patent family, “Food and beverage compositions infused with lipophilic active agents and methods of use thereof” under which 14 of Lexaria’s patents have been granted.


Stock Market & Investing Books

Enter a stock symbol to view the stock details.